Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘McGuireWoods LLP’ returned 3,630 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Are Venture Capitalists Primed for Increased Activity in 2011?

    In a recent survey by the National Venture Capital Association and Dow Jones VentureSource, a majority of U.S. venture capitalists stated they are optimistic for 2011 and plan to expand investments generally.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Arlington County, Virginia, To Consider Expediting Outdoor Cafe Approvals

    On June 13, 2023, the Arlington County Board adopted a request to advertise the Future of Outdoor Dining (FOOD) study.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
McGuireWoods LLP
  • Article

    CMS Finalizes Rules For ESRD Dialysis Payment System And Incentive Program

    Private equity investors continue to be active investors in the dialysis industry, as we’ve frequently discussed in the past, including in the Law360 report on "Private Equity Interest in the Dialysis Sector Continues to Thrive" that can be accessed here.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Comvest Partners Closes PE Fund At $893 Million

    Comvest Partners has announced the close of its fifth PE fund.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Congress Expands Medicare Coverage For Acute Dialysis Services

    On June 29, 2015, President Obama signed into law the Trade Preferences Extension Act of 2015, which provides for Medicare reimbursement for renal dialysis services furnished to individuals with acute kidney injury.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Congress Passes Last-Minute Fix To Save FDA Generic Drug User Fee Funds, Leaves Unaddressed Device User Fee Funds

    In a last-minute bid to save the generic drug user fee program, the Senate approved a bill that will allow the Food and Drug Administration to begin collecting new generic drug user fees on Oct. 1.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    DaVita Agrees To $350 Million Settlement To Resolve Illegal Kickbacks Allegations

    DaVita Healthcare Partners has agreed to pay $350 million to resolve claims it violated the False Claims Act, according to a Department of Justice press release.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    FDA Provides New Resource On Redundancy Risk Management Plans For Critical Food Manufacturers

    On Nov. 22, 2023, the U.S. Food and Drug Administration (FDA) published a new resource for manufacturers of critical foods...
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Health Care Fraud And Abuse Enforcement

    Several hospitals and health systems have recently settled Anti-Kickback Statute, Stark Law and False Claims Act allegations with the Department of Justice.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Roundup: Jiff, iHealth, CVRx and Zyga Technology Secure Financing

    Over the past week, Jiff, iHealth Lab, CVRx and Zyga Technology have all separately announced completion of financing rounds.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Ampersand And GHO Acquire Avid Bioservices For $1.1 Billion

    Ampersand Capital Partners and GHO Capital Partners will acquire Avid Bioservices for approximately $1.1 billion, according to a news release.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Arlington Capital Acquires TEAM Technologies From Clearlake

    Arlington Capital Partners has announced its acquisition of TEAM Technologies from Clearlake Capital Group.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Coalesce Capital Recapitalizes Examinetics

    Coalesce Capital has announced it has participated in a recapitalization of Examinetics.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Dune Medical Devices Secures $21 Million In Financing

    Dune Medical Devices has announced it completed the first of a two-stage $21 million equity financing.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Grant Avenue Acquires QHR Health

    Grant Avenue Capital has announced it acquired a majority interest in QHR Health from Quorum Health Corp.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Hildred To Acquire Hello Bello

    Hildred Capital Management will acquire Hello Bello, according to a news release. Hello Bello, founded in 2019 and based in Pacific Palisades, Calif., produces baby and family care products.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Irhythm Technologies Secures $17 Million In Financing

    iRhythm Technologies has announced it completed raising $17 million in series E financing.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Ivantis Completes $46.5 Million In Financing

    Ivantis, Inc. has announced it has raised $46.5 million in series B financing.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: New Mountain To Acquire Machinify

    New Mountain Capital has announced it will acquire Machinify.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Healthcare & Life Sciences Private Equity Deal Tracker: Pamplona Capital Management Acquires Medassets For $2.7B

    Pamplona Capital Management has announced it will acquire MedAssets for $2.7 billion.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Showing 901–920 of 3630 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics